Background: Myeloid-derived suppressor cells (MDSCs) is a heterogenous cell population having
an ability to suppress T-cell function. Due to their suppressive effects on immunity,
MDSCs has been known to be associated with poor prognosis in various solid cancers.
However, the role of MDSC in myeloid neoplasm are unclear. So, we elucidated the role
of leukemic subpopulation showing CD11b+CD33+HLA-DR− immunophenotype, which resembles MDSCs.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to CytotherapyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
